Last reviewed · How we verify

NCT05852093

Clinical Study on the Effect of Tizanidine on the Function and Pain of Patients After Shoulder Arthroscopy

Not yet recruiting EARLY_PHASE1 Last updated 10 May 2023
What this trial tests

EARLY_PHASE1 trial testing Celecoxib+Buprenorphine Transdermal Patch in Rotator Cuff Tears in 100 participants. Not yet recruiting.

Timeline
1 June 2023
Primary endpoint
1 June 2026
1 June 2027

Quick facts

Lead sponsorSecond Affiliated Hospital, School of Medicine, Zhejiang University
PhaseEARLY_PHASE1
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment100
Start date1 June 2023
Primary completion1 June 2026
Estimated completion1 June 2027

Drugs / interventions tested

Conditions studied

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Who can join

Adults 20 to 70, any sex, with Rotator Cuff Tears. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The perspective, randomized controlled trial is to investigate and evaluate the effect of Tizanidine on the function and pain of patients with rotator cuff tear after shoulder arthroscopy;

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Rotator Cuff Tears

Currently open trials in the same condition.

Other Second Affiliated Hospital, School of Medicine, Zhejiang University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05852093.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing